Open for inclusion

A phase II single arm clinical trial of nivolumab (BMS936558) in subjects with metastatic or unresectable urothelial cancer who have progressed or recurred following treatment with a platinum agent

Cancer type: Bladder cancer

Phase: II

Principal Investigator: Peltola Katriina

Country: FI

Keywords: Finland, Helsinki

Status: Open for inclusion

Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02387996